ASI Advisory Board

Our advisory board consists of some of the world’s leading experts in pathology, genetics, and bio-physics. The members of the board help steer the direction of ASI through strategic meetings, as well as offering feedback and advice on a regular basis.

Keith J. Kaplan, MD

A surgical pathologist and Chief Information Officer (CIO) of Carolinas Pathology Group, Celligent Diagnostics and Diligent Billing and Management.

Dr. Kaplan is a native of Chicago and a graduate of Michigan State University. He is a graduate of Northwestern University Feinberg School of Medicine and completed residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC. While at Walter Reed, Dr. Kaplan was named Resident of the Year, and in conjunction with the Armed Forces Institute of Pathology, Dr. Kaplan founded and directed the Army Telepathology Program. This Program connected 25 hospitals internationally for consultation via telepathology. Dr. Kaplan also served as the Medical Director and Consulting Pathologist of Laboratory Services at Keller Army Hospital in West Point, New York.

Dr. Kaplan is board certified in anatomic and clinical pathology. His subspecialty interests include gastrointestinal and hepatic pathology, cytopathology and pathology informatics as well as research interests in gastrointestinal and hepatobiliary pathology, hyperspectral imaging, image analysis and the integration of Web in pathology. He has authored over 60 peer-reviewed scientific articles, book chapters, editorials and scientific abstracts and frequently lectures at both national and international meetings on topics related to pathology informatics. Prior to joining Carolinas Pathology Group, Dr. Kaplan was a surgical pathologist at Mayo Clinic, Rochester, Minnesota and also held the academic post of associate professor of pathology at Mayo Medical School.

As CIO, Dr. Kaplan is responsible for all aspects of informatics strategies, operations, and projects and processes that encompass laboratory, healthcare and research information systems for Carolinas Pathology Group.

Dr. Kaplan currently serves as a member of the College of American Pathologists, American Society of Clinical Pathology and the American Society of Cytopathology as well as the American Pathology Foundation. He is also an executive board member of the Digital Pathology Association. Dr. Kaplan has previously served as a member of the College of American Pathologists Informatics Committee, Standards Committee, and Instrumentation Resource Committee and as co-chair of the American Telemedicine Association Telepathology Special Interest Group.

Prof. Yuval Garini, PhD

Professor, Physics Department and Institute of Nanotechnology, Bar-Ilan University.

Prof. Yuval Garini is a Senior Lecturer at the Department of Physics and member of the Institute of Nanotechnology and Advanced Materials (BINA) in Bar Ilan University. His group focuses on the field of physical biology and their research combines the development of imaging methods for the study of sub-cellular biology and genetics with the use of advanced single molecule detection techniques to explore various biological systems.

Prof. Garini has years of experience in the fields of biophysics, the applications of novel optical methods to biomedical applications and the use of physical methods for analyzing biological systems. Among his current research studies, he is studying the mechanisms for the organization of the genome in the cell nucleus, and using single-molecule methods for studying protein-DNA interaction.

Steven Anderson, Ph.D

Senior Vice President and Chief Scientific Officer for Genetics and Oncology, Laboratory Corporation of America.

Steven Anderson, Ph,D. is a Senior Vice-President in LabCorp and Chief-Scientific Officer for Genetics and Oncology.  He is also the Director of Operations for the Center for Molecular Biology and Pathology in Research Triangle Park.  He has been in the LabCorp organization for over 20 years and has held a variety of positions including Director of Operations for ViroMed Laboratories, Director of Operations for Monogram Biosciences, and National Director of Research and Development. Dr. Anderson is a member of a variety of professional societies including the American Society for Human Genetics, the American Association for Cancer Research and the Association for Molecular Pathology.

Dr. Anderson’s research interests are in the development and applications for molecular diagnostics.  He has authored more than 150 articles and abstracts published in such journals as Genetics, Proceedings of the National Academy of Sciences, Clinical Chemistry, the Journal of Infectious Disease, Human Pathology, American Journal of Obstetrics and Gynecology, Oncogene, the Journal of the National Cancer Institute, Clinical Cancer Research, Breast Cancer Research, BMC Cancer, the Journal of Molecular Diagnostics and Expert Reviews in Molecular Diagnostics.

He received his B.A. in biology from St. Cloud State University, his Ph.D. in Genetics from Iowa State University, and was an American Cancer Society post-doctoral fellow at the Waksman Institute of Rutgers University.

Craig Mckee

Director of Cytology/FISH Laboratory Operations, PLUS diagnostics.

Craig McKee is the Director of Operations for PLUS Diagnostics.  PLUS Diagnostics is an anatomical pathology laboratory with CLIA-certification and CAP accreditation in cytology, histology and molecular pathology. Craig brings extensive experience in laboratory practices and specialized research in development, validation and implementation of new laboratory procedures with expertise in genetics-based assays. 

For the past 20 years, Craig has managed cytogenetic operations in a variety of national laboratories.  He holds strong affiliations with the National Certification Agency for Medical Laboratory Personnel, as well as the Association of Genetic Technologists.

Dr. Jeremy Squire

Professor and Research Chair in Molecular Pathology in the Department of Pathology and Molecular Medicine, Queens University. 

From 1999-2008  Dr. Jeremy Squire held the positions of Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto; a Senior Scientist, Ontario Cancer Institute, and was the first holder of the J.C. Boileau Grant Chair in Oncologic Pathology.

In 2008 Dr. Squire moved his laboratory to Kingston, Ontario and accepted the positions of Professor and Research Chair in Molecular Pathology in the Department of Pathology and Molecular Medicine at Queen's University and Kingston General Hospital; and, Director of Translational Laboratory Research, NCIC – Clinical Trials Group.  He also served as Acting Director of the Clinical Cytogenetics Service Laboratory at the Kingston General Hospital from 2009 - 2011.

Dr. Squire’s program is strongly oriented towards translational research using molecular, genomic and cytogenetic methods to provide new information and hypotheses concerning the onset, cause and progression of cancer.  He has been a champion of molecular cytogenetic cancer research and was among the first in the world to apply spectral karyotyping (SKY), comparative genomic hybridization (CGH), microarray comparative genomic hybridization, and molecular analysis of epigenomic changes in tumours.  His research groups in Toronto and in Kingston have been among the most productive in this field, with over 300 original peer-reviewed papers, chapters and reviews in the area of the molecular cytogenetics and the genomics of solid tumors and leukemias.

With a strong reputation in the use of novel sophisticated technologies for the detection of cancer, he has elucidated clinically important processes that are operative during early steps of cancer initiation, and on multiple changes that affect genes, chromosomes and proteins during tumour progression.

Dr. Felipe Dominguez 

The President of  SunCoast Pathology Associates Inc., a leading independent clinical laboratory based in Florida.

Dr. Dominguez received his medical degree from CETEC University Santo Domingo and completed his residency training in Anatomic and Clinical Pathology at Mount Sinai Medical Center of Florida. Dr. Dominguez  is board certified in Anatomic and Clinical Pathology.  

As the President of SunCoast Pathology Associates Inc., Dr. Dominguez is overseeing all aspects of the medical practice in SunCoast, which includes a broad range of pathology-related services. 

Prof. Dr. Schröck

Prof. Dr. Schröck is the Director  of Functional Tumor Genetics Division at the Institute of Clinical Genetics, Technical University of Dresden. 

Prof. Schröck has many years’ experience in the genetic investigation of brain tumors and other cancers, using spectral karyotyping (SKY) and comparative genomic hybridization (CGH) Among her current research studies, Prof Schröck examined tumors using genome-wide high-throughput sequencing (next generation sequencing).

An important goal of her research is accurate and fast scientific findings which then can be implemented into clinical trials and ultimately, used in patient care.
Dr. Schröck has also recently been appointed as President  of Scientific Board of  International Society of Cellular Oncology (ISCO).

ISCO is a strong alliance of active researchers in the field of cancer that crosses many disciplines including medical oncology, molecular and cell pathology, genomics, proteomics, epigenomics, biochemistry, specialist microscopy, molecular imaging, biotechnology and bioinformatics.

Laurence Nore

MBA, Strategic Marketing and Business Development Executive with experience in the Diagnostic and Biotech industries.

Most recently Laurence Nore was Director of Business Development at Ventana Medical Systems/Roche Diagnostics, the leader in tissue-based cancer diagnostics, where she led the collaboration with ASI as well as the acquisition of BioImagene. Prior to Ventana she was responsible for the launch of a Breast Cancer genetic test developed at Perlegen and developed the investment rationale for their Series E round. Laurence Nore also brings several years of experience in Therapeutics at Amgen and PDL BioPharma. She holds an MBA from the Anderson School at UCLA.